IL‐7 germline variant: setting the stage for immune‐related adverse events

Treatment with immune checkpoint inhibitors (ICIs) is frequently associated with immune‐related adverse events (irAEs). A new study identified an interleukin 7 (IL‐7) allelic variant—rs16906115—as a major risk factor for the development of ICI‐associated irAEs. This association is of great significa...

Descripción completa

Detalles Bibliográficos

Autores principales:	Hussein Issaoui, Jean‐Ehrland Ricci
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2023-03-01
Colección:	Molecular Oncology
Materias:	germline variant immune checkpoint inhibitors immune‐related adverse events interleukin 7 lymphocytes
Acceso en línea:	https://doi.org/10.1002/1878-0261.13392
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!